Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,084,333
-
Share change
-
-2,026,760
-
Total reported value
-
$213,291,000
-
Put/Call ratio
-
166%
-
Price per share
-
$9.24
-
Number of holders
-
88
-
Value change
-
-$16,512,458
-
Number of buys
-
57
-
Number of sells
-
28
Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) as of Q4 2020
As of 31 Dec 2020,
SURFACE ONCOLOGY INC - COM (SURF) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,084,333 shares.
The largest 10 holders included
Atlas Venture Associates IX, LLC, Atlas Venture Associates IX, LLC, ARK Investment Management LLC, VR Adviser, LLC, MORGAN STANLEY, FMR LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, Ghost Tree Capital, LLC, and Acuta Capital Partners, LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.